<?xml version="1.0" encoding="UTF-8"?>
<ref id="b21-1031654">
 <label>21.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Amadori</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Stasi</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Martelli</surname>
    <given-names>AM</given-names>
   </name>
  </person-group>
  <article-title>Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML1107)</article-title>
  <source>Br J Haematol</source>. 
  <year>2012</year>;
  <volume>156</volume>(
  <issue>2</issue>):
  <fpage>205</fpage>â€“
  <lpage>212</lpage>.
  <pub-id pub-id-type="pmid">22082314</pub-id>
 </mixed-citation>
</ref>
